Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
Price and Volume
Detailed Quote| Volume | 405,957 |
| Open | 1.970 |
| Bid (Size) | 1.980 (2,500) |
| Ask (Size) | 1.990 (4,300) |
| Prev. Close | 2.000 |
| Today's Range | 1.950 - 2.040 |
| 52wk Range | 1.330 - 2.610 |
| Shares Outstanding | 31,056,238 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
23.9% below 52-week high
1.985
1.3352W Low
2.6152W High
1 Week
5.3% below 1-week high
1.931W Low
2.101W High
Inhibikase Therapeutics, Inc. - Common Stock (IKT) traded between $1.33 and $2.61 over the past 52 weeks and last traded at $1.99, 23.9% below its 52-week high. Over the past week it ranged between $1.93 and $2.10.
Past 12 Months
1W
-$0.03
1M
-$0.45
3M
+$0.01
6M
+$0.20
YTD
+$0.04
1Y
+$0.36
IKT was +22.5% over the past year, +10.9% over six months, +1.8% year to date, -1.7% in the last week.
12 Months vs Market
IKT
+22.5%
DIA
+10.2%
SPY
+16.0%
QQQ
+25.0%
IWM
+13.9%
Over the past 12 months IKT returned +22.5% versus DIA (Dow) +10.2%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +25.0% and IWM (Russell 2000) +13.9%.
Volume & Liquidity
0.60× 3-mo avg
Today 405,957
3-mo avg 672.6K
1W
459.3K
1M
577.2K
3M
672.6K
6M
758.1K
YTD
1.1M
1Y
925.1K
IKT most recently traded 405,957 shares against a 3-month average daily volume of 672.6K.
More News
Read More
In today's session, these stocks are experiencing unusual volume. ↗
February 24, 2026
These stocks are gapping in today's session ↗
February 23, 2026
These stocks are moving in today's pre-market session ↗
February 23, 2026
Thursday's after hours session: top gainers and losers ↗
December 25, 2025
Which stocks are moving after the closing bell on Wednesday? ↗
December 24, 2025
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 20, 2025
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 18, 2025
These stocks are moving in today's pre-market session ↗
August 18, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 18, 2025
Inhibikase Posts Wider Loss in Q2 ↗
August 14, 2025
Frequently Asked Questions
Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.985
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 10/06/26 03:58 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 61.65M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 62M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.